930356134	930356134	CD	B-NP	O
|	|	NN	I-NP	O
FFACH	FFACH	NN	I-NP	O
|	|	NN	I-NP	O
62110638	62110638	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4529300	4529300	CD	B-NP	O
|	|	CC	I-NP	O
10/8/2005	10/8/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/2005	11/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
ZOGG	ZOGG	NN	B-NP	B-protein
,	,	,	O	O
RAYMOND	RAYMOND	NNP	B-NP	O
RANDALL	RANDALL	NNP	I-NP	O
MD	MD	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
:	:	:	O	O
Presumed	Presumed	NNP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
10/9/05	10/9/05	CD	B-NP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
ONCOLOGIST	ONCOLOGIST	NN	I-NP	O
:	:	:	O	O
Antoine	Antoine	NNP	B-NP	O
Petchulis	Petchulis	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Pain	Pain	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Recurrent	Recurrent	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
brief	brief	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-year-old	57-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
follicular	follicular	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
approximately	approximately	RB	B-NP	O
eight	eight	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
CVP	CVP	NN	B-NP	B-protein
and	and	CC	I-NP	O
CHOP/Rituxan	CHOP/Rituxan	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
high-dose	high-dose	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
and	and	CC	O	O
autologous	autologous	JJ	B-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
rescue	rescue	NN	I-NP	O
in	in	IN	B-PP	O
6/22	6/22	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
impaired	impaired	JJ	I-NP	O
lung	lung	NN	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
oxygen	oxygen	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transplant	transplant	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
4/9	4/9	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
eventually	eventually	RB	B-VP	O
was	be	VBD	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
recurrent	recurrent	JJ	B-ADJP	O
or	or	CC	O	O
increasing	increase	VBG	B-VP	O
disease	disease	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
retroperitoneum	retroperitoneum	NN	I-NP	O
by	by	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
paraaortic	paraaortic	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
L2	L2	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
pursue	pursue	VB	I-VP	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
completed	complete	VBD	B-VP	O
on	on	IN	B-PP	O
10/4/05	10/4/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	NN	I-NP	O
lower	low	JJR	B-ADVP	O
back	back	RB	B-ADVP	O
radiating	radiate	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
band-like	band-like	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
waist	waist	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
abdomen	abdoman	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
and	and	CC	I-NP	O
buttock	buttock	NN	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
also	also	RB	B-ADVP	O
radiated	radiate	VBD	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
for	for	IN	B-PP	O
weightbearing	weightbeare	VBG	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
occasionally	occasionally	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
numbness	numbness	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
radiation	radiation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
to	to	TO	B-PP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
numbness	numbness	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
back	back	JJ	B-NP	O
or	or	CC	I-NP	O
saddle	saddle	JJ	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
bowel	bowel	NN	B-NP	O
or	or	CC	I-NP	O
bladder	bladder	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
fluoroscopic	fluoroscopic	JJ	B-NP	O
LP	LP	NN	I-NP	O
on	on	IN	B-PP	O
6/18/05	6/18/05	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
69	69	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
protein	protein	NN	I-NP	O
of	of	IN	B-PP	O
49.3	49.3	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cytology	cytology	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Plain	Plain	NN	B-NP	O
films	film	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
showed	show	VBD	B-VP	O
enthesopathy	enthesopathy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
superior	superior	JJ	I-NP	O
pelvis	pelvis	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
lumbar	lumbar	JJ	I-NP	O
spine	spine	NN	I-NP	O
degeneration	degeneration	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sclerotic	sclerotic	JJ	B-NP	O
focus	focus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
femur	femur	NN	I-NP	O
.	.	.	O	O

MRI	MRI	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lumbar	lumbar	JJ	I-NP	O
spine	spine	NN	I-NP	O
on	on	IN	B-PP	O
8/5/05	8/5/05	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
mass	mass	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
retroperitoneum	retroperitoneum	NN	I-NP	O
centered	center	VBD	B-VP	O
anterior	anterior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
spine	spine	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
L2	L2	NN	B-NP	B-DNA
,	,	,	O	O
position	position	NN	B-NP	O
posterior	posterior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IVC	IVC	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
aorta	aorta	NN	I-NP	O
measuring	measure	VBG	B-VP	O
4.5	4.5	CD	B-NP	O
x	x	SYM	I-NP	O
2.7	2.7	CD	I-NP	O
x	x	SYM	I-NP	O
3.4	3.4	CD	I-NP	O
cm	cm	NN	I-NP	O
;	;	:	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
lesion	lesion	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
superior	superior	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
L2	L2	NN	I-NP	B-DNA
vertebral	vertebral	JJ	I-NP	O
body	body	NN	I-NP	O
continuous	continuous	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
paraspinal	paraspinal	JJ	I-NP	O
mass	mass	NN	I-NP	O
with	with	IN	B-PP	O
wedging	wedge	VBG	B-VP	O
and	and	CC	O	O
probable	probable	JJ	B-NP	O
pathologic	pathologic	JJ	I-NP	O
compression	compression	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
epidural	epidural	JJ	I-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
to	to	TO	B-PP	O
BCNU	BCNU	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Imuran	Imuran	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
6	6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

MiraLax	MiraLax	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Paxil	Paxil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

MS-Contin	MS-Contin	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Flexeril	Flexeril	NNP	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
latex	latex	RB	B-ADVP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
brain	brain	NN	I-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O

Mother	Mother	DT	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
uterine	uterine	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
in	in	IN	B-PP	O
Holl	Holl	NNP	B-NP	O
Cho	Cho	NNP	I-NP	O
Shing	Shing	NNP	I-NP	O
She	She	NNP	I-NP	O
denies	deny	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
and	and	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
four	four	CD	B-NP	O
grown	grown	JJ	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.6	97.6	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
91	91	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/90	140/90	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
with	with	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
standing	stand	VBG	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
sclerae	sclerae	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
conjunctivae	conjunctiva	NNS	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Moist	Moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
and	and	CC	O	O
clear	clear	JJ	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	RB	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Clear	Clear	NNP	B-NP	O
to	to	TO	B-VP	O
auscultation	auscultation	VB	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
wheeze	wheeze	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Morbid	Morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
normoactive	normoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Back	Back	RB	B-ADVP	O
:	:	:	O	O
Mild	Mild	JJ	B-NP	O
paraspinal	paraspinal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
2/5	2/5	CD	B-NP	O
hip	hip	NN	I-NP	O
flexion	flexion	NN	I-NP	O
and	and	CC	I-NP	O
knee	knee	NN	I-NP	O
extension	extension	NN	I-NP	O
and	and	CC	I-NP	O
flexion	flexion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
;	;	:	O	O
5/5	5/5	CD	B-NP	O
hip	hip	NN	I-NP	O
flexion	flexion	NN	I-NP	O
and	and	CC	I-NP	O
knee	knee	NN	I-NP	O
extension	extension	NN	I-NP	O
and	and	CC	I-NP	O
flexion	flexion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
;	;	:	O	O
5/5	5/5	CD	B-NP	O
hip	hip	NN	I-NP	O
flexion	flexion	NN	I-NP	O
and	and	CC	I-NP	O
knee	knee	NN	I-NP	O
extension	extension	NN	I-NP	O
and	and	CC	I-NP	O
flexion	flexion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
;	;	:	O	O
distal	distal	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
9.8	9.8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
35.5	35.5	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
249	249	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
2.1	2.1	CD	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
45.8	45.8	CD	I-NP	I-protein
.	.	.	O	O

BMP	BMP	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
139	139	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
99	99	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
19	19	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
126	126	CD	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

UA	UA	NNP	B-NP	O
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
white	white	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57-year-old	57-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
follicular	follicular	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
for	for	IN	B-PP	O
workup	workup	NN	B-NP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
back	back	NN	I-NP	O
pain	pain	NN	I-NP	O
recurring	recur	VBG	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
XRT	XRT	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lumbar	lumbar	JJ	I-NP	B-DNA
spine	spine	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Oncology	Oncology	NNP	B-NP	O
:	:	:	O	O
CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
thoracic	thoracic	JJ	I-NP	O
,	,	,	I-NP	O
lumbar	lumbar	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sacral	sacral	JJ	B-NP	O
spine	spine	NN	I-NP	O
on	on	IN	B-PP	O
8/18/05	8/18/05	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
cord	cord	NN	B-NP	O
compression	compression	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
a	a	DT	B-NP	O
compression	compression	NN	I-NP	O
fracture	fracture	NN	I-NP	O
at	at	IN	B-PP	O
L2	L2	NN	B-NP	B-DNA
.	.	.	O	O

IR	IR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
on	on	IN	B-PP	O
4/18/05	4/18/05	CD	B-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
kyphoplasty	kyphoplasty	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
deferred	defer	VBD	B-VP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
hip	hip	VB	I-VP	O
pathology	pathology	NN	B-NP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
lumbar	lumbar	JJ	B-NP	O
spine	spine	NN	I-NP	O
pathology	pathology	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
on	on	IN	B-PP	O
4/18/05	4/18/05	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
acetabulum	acetabulum	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
associated	associate	VBN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Radiation	Radiation	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Cestia	Cestia	NNP	I-NP	O
with	with	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
deferred	defer	VBD	B-VP	O
any	any	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
completion	completion	NN	I-NP	O
of	of	IN	B-PP	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
started	start	VBD	B-VP	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
on	on	IN	B-PP	O
3/29/05	3/29/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
contact	contact	NN	I-NP	O
in	in	IN	B-PP	O
Radiation	Radiation	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
is	be	VBZ	B-VP	O
Britt	Britt	NNP	B-NP	O
L	L	NNP	I-NP	O
Redden	Redden	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
pager	pager	NN	B-NP	O
number	number	NN	I-NP	O
28468	28468	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
treatments	treatment	NNS	I-NP	O
of	of	IN	B-PP	O
radiation	radiation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
then	then	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
's	's	POS	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Saralegui	Saralegui	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
meet	meet	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Strief	Strief	NNP	I-NP	O
on	on	IN	B-PP	O
9/8/05	9/8/05	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
Per	Per	NNP	I-NP	O
recommendations	recommendation	NNS	I-NP	O
of	of	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
and	and	CC	O	O
Physical	Physical	NNP	B-NP	O
Therapy	Therapy	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
touched	touch	VBN	I-VP	O
down	down	RP	B-PRT	O
weightbearing	weightbeare	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
toes	toe	NNS	I-NP	O
only	only	RB	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
and	and	CC	I-NP	O
full	full	JJ	I-NP	O
weightbearing	weightbearing	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
expected	expect	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
undergo	undergo	VB	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
hip	hip	NN	I-NP	O
precaution	precaution	NN	I-NP	O
with	with	IN	B-PP	O
limitation	limitation	NN	B-NP	O
of	of	IN	B-PP	O
hip	hip	NN	B-NP	O
flexion	flexion	NN	I-NP	O
and	and	CC	O	O
internal	internal	JJ	B-NP	O
rotation	rotation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Pain	Pain	NNP	I-NP	O
Service	Service	NNP	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
current	current	JJ	I-NP	O
pain	pain	NN	I-NP	O
regimen	regimen	NN	I-NP	O
includes	include	VBZ	B-VP	O
methadone	methadone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

a.m.	a.m.	RB	B-ADVP	O
and	and	CC	I-ADVP	O
q.	q.	RB	I-ADVP	O
noon	noon	NN	B-NP	O
,	,	,	O	O
MSIR	MSIR	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
15-30	15-30	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
2h	2h	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Decadron	Decadron	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
compression	compression	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
tapering	taper	VBG	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Decadron	Decadron	NNP	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
with	with	IN	B-PP	O
taper	taper	NN	B-NP	O
as	as	IN	B-SBAR	O
listed	list	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
completed	complete	VBN	I-VP	O
Decadron	Decadron	NNP	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
then	then	RB	I-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dosing	dosing	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
receive	receive	VB	I-VP	O
pamidronate	pamidronate	NN	B-NP	B-protein
90	90	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
x1	x1	NN	I-NP	I-protein
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
UA	UA	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADVP	O
or	or	CC	I-ADVP	O
less	less	RBR	B-ADJP	O
benign	benign	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
culture	culture	NN	I-NP	O
remained	remain	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
five-day	five-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
five	five	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
genital	genital	JJ	I-NP	O
herpes	herpes	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
continued	continue	VBN	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
itching	itching	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
fluconazole	fluconazole	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x1	x1	NN	I-NP	I-protein
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
a	a	DT	B-NP	O
presumed	presumed	JJ	I-NP	O
yeast	yeast	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
constipation	constipation	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
good	good	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
on	on	IN	B-PP	O
MiraLax	MiraLax	NNP	B-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
writing	write	VBG	I-VP	O
for	for	IN	B-PP	O
Dulcolax	Dulcolax	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
given	give	VBN	B-VP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
so	so	RB	O	O
her	her	PRP$	B-NP	O
dosing	dosing	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
2.3	2.3	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
on	on	IN	B-PP	O
dosing	dosing	NN	B-NP	O
of	of	IN	B-PP	O
4.5	4.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
require	require	VB	I-VP	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
for	for	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiovascular	cardiovascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
on	on	IN	B-PP	O
1/28/04	1/28/04	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
Decadron	Decadron	NNP	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
intended	intend	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
Decadron	Decadron	NNP	I-NP	O
taper	taper	NN	I-NP	O
has	have	VBZ	B-VP	O
finished	finish	VBN	I-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
,	,	,	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
hypocalcemia	hypocalcemia	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Tums	Tum	NNS	B-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
pamidronate	pamidronate	NN	B-NP	O
x1	x1	NN	I-NP	O
as	as	IN	B-SBAR	O
listed	list	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ensers	Enser	NNS	I-NP	O
1	1	CD	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
lytic	lytic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
fracture	fracture	NN	B-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	O
recommendations	recommendation	NNS	I-NP	O
of	of	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
limit	limit	NN	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
to	to	TO	B-VP	O
touchdown	touchdown	VB	I-VP	O
weightbearing	weightbeare	VBG	I-VP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
full	full	JJ	B-NP	O
weightbearing	weightbearing	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
involving	involve	VBG	B-VP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-PP	O
completion	completion	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kelvin	Kelvin	NNP	I-NP	O
Lang	Lang	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
Orthopedic	Orthopedic	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
on	on	IN	B-PP	O
9/8/05	9/8/05	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
;	;	:	O	O
Dulcolax	Dulcolax	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
;	;	:	O	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Flexeril	Flexeril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
dexamethasone	dexamethasone	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
doses	dose	VBZ	B-VP	O
then	then	RB	B-ADVP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x3	x3	NN	I-NP	O
doses	dose	NNS	I-NP	O
then	then	RB	B-ADVP	O
start	start	VBP	B-VP	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Sennosides	Sennosides	NNP	B-NP	O
two	two	CD	B-NP	O
tables	table	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4.5	4.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
MSIR	MSIR	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
MSIR	MSIR	NN	B-NP	O
50-30	50-30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
2h	2h	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Paxil	Paxil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Mepron	Mepron	NNP	B-NP	O
750	750	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
a.m.	a.m.	NN	I-NP	I-protein
and	and	CC	I-NP	O
q.	q.	NN	I-NP	O
noon	noon	NN	I-NP	O
,	,	,	O	O
MiraLax	MiraLax	NNP	B-NP	O
17	17	CD	I-NP	O
g	g	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-9126921	1-9126921	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Chadwick	Chadwick	NNP	B-NP	O
Kaua	Kaua	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Chocollmiho	Chocollmiho	NNP	I-NP	O
Valedelp	Valedelp	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Melvin	Melvin	NNP	B-NP	O
Norris	Norris	NNP	I-NP	O
Bernacki	Bernacki	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Arl	Arl	NNP	I-NP	O
Wayne	Wayne	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WEINZINGER	WEINZINGER	NNP	B-NP	O
,	,	,	O	O
DONTE	DONTE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WAUTERS	WAUTERS	NNP	B-NP	O
,	,	,	O	O
GAYLE	GAYLE	NNP	B-NP	O
KENDALL	KENDALL	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8394807	8394807	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/9/05	10/9/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/9/05	10/9/05	CD	B-NP	O

